Sandbox g2: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
mNo edit summary
Line 1: Line 1:


<ul class="mw-collapsible" data-expandtext="Preferred regimen" data-collapsetext="Preferred regimen">
<ul class="mw-collapsible" data-expandtext="Preferred regimen" data-collapsetext="Preferred regimen">
<li>{{abx|Cefotaxime 8–12 g/day q4–6h|Ceftriaxone 4 g/day q12h}} {{and}} {{abx|Metronidazole 30 mg/kg/day q6h}}</li>
<li>Cefotaxime 8–12 g/day q4–6h OR Ceftriaxone 4 g/day q12h AND Metronidazole 30 mg/kg/day q6h</li>
</ul>
 
 
 
 
<ul class="mw-collapsible" data-expandtext="Signs and Symptoms" data-collapsetext="Signs and Symptoms">
<li> Fever (&gt;38.3°C)</li>
<li> Hypothermia (core temperature &lt;36°C)</li>
<li> Heart rate &gt;90/min–1 or more than two SD above the normal value for age</li>
<li> Tachypnea</li>
<li> Altered mental status</li>
<li> Significant edema or positive fluid balance (&gt;20 mL/kg over 24 hr)</li>
<li> Hypotension (SBP &lt;90 mm Hg, MAP &lt;70 mm Hg, or an SBP decrease &gt;40 mm Hg)</li>
<li> Hypoxemia (Pao2/Fio2 &lt;300)</li>
<li> Acute oliguria (urine output &lt;0.5 mL/kg/hr for at least 2 hrs despite adequate fluid resuscitation)</li>
<li> Ileus (absent bowel sounds)</li>
<li> Diminished capillary refill or mottling</li>
</ul>
</ul>

Revision as of 02:12, 18 April 2015

  • Cefotaxime 8–12 g/day q4–6h OR Ceftriaxone 4 g/day q12h AND Metronidazole 30 mg/kg/day q6h